Iterum Therapeutics plc (ITRMF) Operating cash flow 2016–2024
Iterum Therapeutics plc (ITRMF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$26.8MFY2024 · since FY2016: -$11.3M → -$26.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$26.8M | +31.9% |
| FY2023 | -$39.3M | -112.9% |
| FY2022 | -$18.5M | -16.6% |
| FY2021 | -$15.8M | +70.9% |
| FY2020 | -$54.5M | +33.4% |
| FY2019 | -$81.9M | -6.0% |
| FY2018 | -$77.3M | -152.4% |
| FY2017 | -$30.6M | -170.9% |
| FY2016 | -$11.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice